Avricore Health Inc.
AVCR.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 32.37% | -93.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 32.37% | -93.15% | |||
| Cost of Revenue | 18.02% | -9.31% | |||
| Gross Profit | -9.77% | -114.42% | |||
| SG&A Expenses | -20.34% | 0.90% | |||
| Depreciation & Amortization | 25.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.09% | -0.89% | |||
| Operating Income | 17.01% | -592.98% | |||
| Income Before Tax | 17.00% | -515.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.00% | -515.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.00% | -515.58% | |||
| EBIT | 17.01% | -592.98% | |||
| EBITDA | 19.53% | -1,391.92% | |||
| EPS Basic | 18.18% | -560.00% | |||
| Normalized Basic EPS | 15.00% | -566.67% | |||
| EPS Diluted | 18.18% | -560.00% | |||
| Normalized Diluted EPS | 15.00% | -566.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||